Fidia’s advanced product portfolio supports healthcare professionals throughout all phases of the TIMER protocol, providing targeted solutions for effective wound management and tissue regeneration.

The HYALO4 Care bioactive line, leveraging the unique properties of hyaluronic acid and advanced technologies, supports every stage of the healing process.

Complementing this offering, Hy-Tissue Micrograft technology, introduces a new regenerative approach designed to promote healing in complex and hard-to-heal wounds, reinforcing Fidia’s commitment to innovation in wound care.